This leader, who for the past two years has helped oversee the Agency’s day-to-day functioning and directed special and high-priority initiatives that cut across offices overseeing FDA’s regulation of drugs, medical devices, tobacco and food, and who also served as the Acting Chief Information Officer (CIO), responsible for oversight of the trans-agency technical and data-focused vision plus its implementation, has announced a departure from the Food and Drug Administration.

The post FDA Principal Deputy Commissioner & Acting CIO departs Agency appeared first on G2Xchange Health, a service of MileMarker10.



Please enter your comment!
Please enter your name here